Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 83% ± 12% | |
lung | 20 studies | 73% ± 23% | |
brain | 20 studies | 50% ± 20% | |
intestine | 14 studies | 77% ± 18% | |
eye | 12 studies | 69% ± 28% | |
liver | 9 studies | 67% ± 23% | |
kidney | 9 studies | 83% ± 17% | |
lymph node | 7 studies | 86% ± 9% | |
bone marrow | 6 studies | 75% ± 23% | |
heart | 6 studies | 32% ± 19% | |
uterus | 6 studies | 80% ± 19% | |
pancreas | 5 studies | 79% ± 23% | |
prostate | 5 studies | 72% ± 29% | |
placenta | 4 studies | 86% ± 23% | |
esophagus | 4 studies | 75% ± 17% | |
skin | 4 studies | 82% ± 18% | |
breast | 4 studies | 90% ± 7% | |
ovary | 3 studies | 71% ± 8% | |
adipose | 3 studies | 69% ± 22% | |
adrenal gland | 3 studies | 85% ± 10% | |
stomach | 3 studies | 51% ± 19% | |
thymus | 3 studies | 81% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 68638.27 | 2632 / 2642 | 100% | 2337.65 | 704 / 705 |
skin | 100% | 89667.02 | 1800 / 1809 | 100% | 3977.94 | 471 / 472 |
ovary | 99% | 32731.91 | 178 / 180 | 100% | 3846.82 | 430 / 430 |
intestine | 100% | 50571.75 | 965 / 966 | 99% | 2831.21 | 521 / 527 |
kidney | 100% | 60591.90 | 89 / 89 | 99% | 2763.39 | 889 / 901 |
esophagus | 100% | 68224.87 | 1443 / 1445 | 98% | 2235.02 | 180 / 183 |
bladder | 100% | 59242.38 | 21 / 21 | 98% | 2549.23 | 493 / 504 |
breast | 99% | 34853.32 | 455 / 459 | 99% | 1941.00 | 1103 / 1118 |
lung | 98% | 37467.40 | 567 / 578 | 98% | 2703.35 | 1135 / 1155 |
uterus | 97% | 33463.55 | 165 / 170 | 99% | 2423.06 | 454 / 459 |
prostate | 99% | 37053.38 | 242 / 245 | 97% | 1058.88 | 487 / 502 |
adrenal gland | 100% | 52177.87 | 257 / 258 | 96% | 1981.63 | 221 / 230 |
thymus | 98% | 33715.69 | 638 / 653 | 98% | 1284.47 | 592 / 605 |
stomach | 86% | 29373.75 | 308 / 359 | 99% | 2422.49 | 282 / 286 |
liver | 87% | 36181.95 | 197 / 226 | 91% | 1230.86 | 370 / 406 |
pancreas | 21% | 4402.63 | 69 / 328 | 96% | 1652.59 | 171 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 2882.55 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 2291.79 | 29 / 29 |
muscle | 100% | 350836.27 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 2879.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 639.71 | 1 / 1 |
blood vessel | 100% | 68942.81 | 1331 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 146830.66 | 925 / 929 | 0% | 0 | 0 / 0 |
adipose | 100% | 39629.99 | 1198 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 34641.83 | 237 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 98158.28 | 828 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050832 | Biological process | defense response to fungus |
GO_0006096 | Biological process | glycolytic process |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0035606 | Biological process | peptidyl-cysteine S-trans-nitrosylation |
GO_0050821 | Biological process | protein stabilization |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0016241 | Biological process | regulation of macroautophagy |
GO_0051873 | Biological process | killing by host of symbiont cells |
GO_0006006 | Biological process | glucose metabolic process |
GO_0017148 | Biological process | negative regulation of translation |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0097452 | Cellular component | GAIT complex |
GO_0031982 | Cellular component | vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_0051287 | Molecular function | NAD binding |
GO_0004365 | Molecular function | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0035605 | Molecular function | peptidyl-cysteine S-nitrosylase activity |
GO_0019828 | Molecular function | aspartic-type endopeptidase inhibitor activity |
GO_0050661 | Molecular function | NADP binding |
GO_0008017 | Molecular function | microtubule binding |
GO_0097718 | Molecular function | disordered domain specific binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GAPDH |
Protein name | Peptidyl-cysteine S-nitrosylase GAPDH Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-) |
Synonyms | CDABP0047 GAPD OK/SW-cl.12 |
Description | FUNCTION: Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively . Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate . Modulates the organization and assembly of the cytoskeleton (By similarity). Facilitates the CHP1-dependent microtubule and membrane associations through its ability to stimulate the binding of CHP1 to microtubules (By similarity). Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes . Upon interferon-gamma treatment assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation . Also plays a role in innate immunity by promoting TNF-induced NF-kappa-B activation and type I interferon production, via interaction with TRAF2 and TRAF3, respectively . Participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis (By similarity). Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC (By similarity). . |
Accessions | E7EUT5 P04406 ENST00000619601.1 [P04406-2] ENST00000229239.10 [P04406-1] ENST00000396859.5 [P04406-1] ENST00000396858.5 [P04406-2] Q0QET7 ENST00000396856.5 ENST00000396861.5 [P04406-1] |